| RS1713844994 |
CLRN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 3, Usher syndrome type 3 |
| RS1713859321 |
CLRN1
|
Health Risk |
Pathogenic |
— |
| RS1713861377 |
CLRN1
|
Health Risk |
Likely pathogenic |
Usher syndrome type 3, Retinitis pigmentosa 61 |
| RS1713866822 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1713910885 |
SI
|
Health Risk |
Pathogenic/Likely pathogenic |
Sucrase-isomaltase deficiency, Sucrase-isomaltase deficiency |
| RS1714102462 |
MCCC1
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS1714132239 |
EVC
|
Health Risk |
Pathogenic/Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1714177959 |
SI
|
Health Risk |
Pathogenic |
Sucrase-isomaltase deficiency, Sucrase-isomaltase deficiency |
| RS1714268814 |
SLC34A2
|
Health Risk |
Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1714292732 |
GNB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease dominant intermediate F, Charcot-Marie-Tooth disease dominant intermediate F |
| RS1714299831 |
SI
|
Health Risk |
Likely pathogenic |
Sucrase-isomaltase deficiency, Sucrase-isomaltase deficiency |
| RS1714390786 |
THPO
|
Health Risk |
Likely pathogenic |
Thrombocythemia 1, Thrombocythemia 1 |
| RS1714397896 |
THPO
|
Health Risk |
Pathogenic |
Thrombocythemia 1, Thrombocythemia 1 |
| RS1714398710 |
EVC
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1714412021 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1714508262 |
IFT80
|
Health Risk |
Conflicting classifications of pathogenicity |
Jeune thoracic dystrophy, Asphyxiating thoracic dystrophy 2 |
| RS1714533252 |
GYG1
|
Health Risk |
Pathogenic |
Glycogen storage disease XV, Polyglucosan body myopathy type 2 |
| RS1714586913 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1714622835 |
MASP1
|
Health Risk |
Pathogenic |
3MC syndrome 1, 3MC syndrome 1 |
| RS1714655118 |
GYG1
|
Health Risk |
Pathogenic |
Glycogen storage disease XV, Polyglucosan body myopathy type 2 |
| RS1714725151 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS1714775017 |
DVL3
|
Health Risk |
Likely pathogenic |
— |
| RS1714805406 |
GNB4
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease dominant intermediate F, Charcot-Marie-Tooth disease dominant intermediate F |
| RS1714806751 |
DNAJC19
|
Health Risk |
Likely pathogenic |
— |
| RS1714831656 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1714833474 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1714837282 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1714839412 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1714842576 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1714843059 |
SOX2
|
Health Risk |
Likely pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1714847764 |
SOX2
|
Health Risk |
Likely pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1714848271 |
LOC108281177;SOX2;SOX2-OT
|
Health Risk |
Pathogenic |
— |
| RS1714851160 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1714858949 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1714861042 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1714861435 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1714864777 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1714865486 |
SOX2
|
Health Risk |
Likely pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1714875635 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1714882477 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1714883683 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1714883776 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1714910248 |
GNB4
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease dominant intermediate F, Charcot-Marie-Tooth disease dominant intermediate F |
| RS1714943416 |
SI
|
Health Risk |
Pathogenic |
— |
| RS1715007577 |
DNAJC19
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria type 5, 3-methylglutaconic aciduria type 5 |
| RS1715035049 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715068106 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715069355 |
IDUA
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715076004 |
TBL1XR1
|
Health Risk |
Likely pathogenic |
— |
| RS1715084294 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715086540 |
IDUA
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715086654 |
IDUA
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis |
| RS1715096917 |
IDUA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715100386 |
TBL1XR1
|
Health Risk |
Likely pathogenic |
Pierpont syndrome, Pierpont syndrome |
| RS1715105181 |
TBL1XR1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 41 |
| RS1715120049 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Hurler syndrome |
| RS1715120552 |
IDUA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715120665 |
IDUA
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715123409 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715144653 |
IDUA
|
Health Risk |
Pathogenic |
— |
| RS1715175636 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715178056 |
IDUA
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-I-H/S |
| RS1715179164 |
IDUA
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715182989 |
SLC2A2
|
Health Risk |
Pathogenic |
Fanconi-Bickel syndrome, Fanconi-Bickel syndrome |
| RS1715188461 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715210316 |
IDUA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715210435 |
IDUA
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-I-H/S |
| RS1715216061 |
IDUA
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715218377 |
IDUA
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715233169 |
IDUA
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715237631 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715248390 |
IDUA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715262294 |
IDUA
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715290919 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715293163 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1715297 |
SLC6A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperekplexia 3, Inborn genetic diseases |
| RS1715314710 |
IDUA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS17153575 |
UROS
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutaneous porphyria, Cutaneous porphyria |
| RS1715390589 |
SLC2A2
|
Health Risk |
Pathogenic |
Fanconi-Bickel syndrome, Fanconi-Bickel syndrome |
| RS17154282 |
SLC26A4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1715435004 |
EVC2
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS17154362 |
SLC26A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Pendred syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1715453232 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1715495987 |
MCCC1
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS1715552187 |
RAB28
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy, Cone-rod dystrophy |
| RS1715585498 |
EVC
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS1715589813 |
CLRN1
|
Health Risk |
Pathogenic |
Usher syndrome type 3A, Usher syndrome |
| RS1715594024 |
CLRN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Neuronal ceroid lipofuscinosis |
| RS1715768907 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1715829134 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1715829691 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS17158558 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hirschsprung disease, susceptibility to |
| RS1716182863 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS1716297832 |
TBL1XR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Intellectual disability |
| RS1716303868 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1716383227 |
IFT80
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS1716457622 |
TBL1XR1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 41 |
| RS1716460260 |
TBL1XR1
|
Health Risk |
Likely pathogenic |
— |
| RS1716484744 |
TBL1XR1
|
Health Risk |
Likely pathogenic |
Pierpont syndrome, Pierpont syndrome |
| RS1716487985 |
CC2D2A
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |